Literature DB >> 360529

Blood group B antigen on renal endothelium as the target for rejection in an ABO-incompatible recipient.

L C Paul, L A van Es, G B Riviere, G Eernisse, J de Graeff.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 360529

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  6 in total

1.  Microvascular phenomena during pancreatic islet graft rejection.

Authors:  M D Menger; B Wolf; R Höbel; H U Schorlemmer; K Messmer
Journal:  Langenbecks Arch Chir       Date:  1991

2.  Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes.

Authors:  M A Galumbeck; F P Sanfilippo; P O Hagen; A V Seaber; J R Urbaniak
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

3.  Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.

Authors:  L Makowka; F A Chapman; D V Cramer; S G Qian; H Sun; T E Starzl
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

Review 4.  Accommodation in ABO-incompatible organ transplants.

Authors:  Mayara Garcia de Mattos Barbosa; Marilia Cascalho; Jeffrey L Platt
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

5.  Antibodies directed against renal collecting ducts in sera of human renal allograft recipients.

Authors:  L C Paul; L A Van Es; M W Kalff; G J Fleuren
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury.

Authors:  J J McPhaul; P Stastny; R B Freeman
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.